Green DM - Search Results

1

Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin.

Frazier AL, Grier HE, Green DM. Frazier AL, et al. Among authors: green dm. Med Pediatr Oncol. 1996 Aug;27(2):69-73. doi: 10.1002/(SICI)1096-911X(199608)27:2<69::AID-MPO1>3.0.CO;2-R. Med Pediatr Oncol. 1996. PMID: 8649322 Clinical Trial.

2

Etoposide, ifosfamide, and cisplatin therapy for refractory childhood solid tumors. Response and toxicity.

van Hoff J, Grier HE, Douglass EC, Green DM. van Hoff J, et al. Among authors: green dm. Cancer. 1995 Jun 15;75(12):2966-70. doi: 10.1002/1097-0142(19950615)75:12<2966::aid-cncr2820751226>3.0.co;2-w. Cancer. 1995. PMID: 7773949 Clinical Trial.

3

Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.

Green DM, Beckwith JB, Breslow NE, Faria P, Moksness J, Finklestein JZ, Grundy P, Thomas PR, Kim T, Shochat S, et al. Green DM, et al. J Clin Oncol. 1994 Oct;12(10):2126-31. doi: 10.1200/JCO.1994.12.10.2126. J Clin Oncol. 1994. PMID: 7931483 Clinical Trial.

4

Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.

Green DM, Breslow NE, Beckwith JB, Moksness J, Finklestein JZ, D'Angio GJ. Green DM, et al. J Clin Oncol. 1994 Oct;12(10):2132-7. doi: 10.1200/JCO.1994.12.10.2132. J Clin Oncol. 1994. PMID: 7931484 Clinical Trial.

5

The effect of chemotherapy dose intensity on the hematological toxicity of the treatment for Wilms' tumor. A report from the National Wilms' Tumor Study.

Green DM, Breslow NE, Evans I, Moksness J, Finklestein JZ, Evans AE, D'Angio GJ. Green DM, et al. Am J Pediatr Hematol Oncol. 1994 Aug;16(3):207-12. doi: 10.1097/00043426-199408000-00004. Am J Pediatr Hematol Oncol. 1994. PMID: 8037337 Clinical Trial.

6

Second malignant tumors following treatment during childhood and adolescence for cancer.

Green DM, Zevon MA, Reese PA, Lowrie GS, Gaeta JF, Pearce JI, Michalek AM, Stephens EA. Green DM, et al. Med Pediatr Oncol. 1994;22(1):1-10. doi: 10.1002/mpo.2950220102. Med Pediatr Oncol. 1994. PMID: 8232073

7

Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.

Green DM, Breslow NE, Evans I, Moksness J, D'Angio GJ. Green DM, et al. Med Pediatr Oncol. 1996 Mar;26(3):147-52. doi: 10.1002/(SICI)1096-911X(199603)26:3<147::AID-MPO1>3.0.CO;2-K. Med Pediatr Oncol. 1996. PMID: 8544795 Clinical Trial.

8

Germline WT1 mutations in Wilms' tumor patients: preliminary results.

Li FP, Breslow NE, Morgan JM, Ghahremani M, Miller GA, Grundy PE, Green DM, Diller LR, Pelletier J. Li FP, et al. Among authors: green dm. Med Pediatr Oncol. 1996 Nov;27(5):404-7. doi: 10.1002/(SICI)1096-911X(199611)27:5<404::AID-MPO3>3.0.CO;2-Q. Med Pediatr Oncol. 1996. PMID: 8827066

9

Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study.

Pratt CB, Maurer HM, Gieser P, Salzberg A, Rao BN, Parham D, Thomas PR, Marcus RB, Cantor A, Pick T, Green D, Neff J, Jenkins JJ. Pratt CB, et al. Med Pediatr Oncol. 1998 Apr;30(4):201-9. doi: 10.1002/(sici)1096-911x(199804)30:4<201::aid-mpo1>3.0.co;2-k. Med Pediatr Oncol. 1998. PMID: 9473754 Clinical Trial.

10

Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group.

Porteus MH, Narkool P, Neuberg D, Guthrie K, Breslow N, Green DM, Diller L. Porteus MH, et al. Among authors: green dm. J Clin Oncol. 2000 May;18(10):2026-31. doi: 10.1200/JCO.2000.18.10.2026. J Clin Oncol. 2000. PMID: 10811666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

758 results

Search Page